Equities

Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC

Actions
  • Price (EUR)120.85
  • Today's Change0.000 / 0.00%
  • Shares traded10.00
  • 1 Year change+8.73%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 16:25 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income415(224)(330)
Depreciation/depletion303027
Non-Cash items352876311
Cash taxes paid, supplemental17895271
Cash interest paid, supplemental333271138
Changes in working capital(53)283175
Total cash from operations1,0921,272779
INVESTING
Capital expenditures(43)(498)(46)
Other investing and cash flow items, total(120)52(5167)
Total cash from investing(163)(446)(5212)
FINANCING
Financing cash flow items(51)(45)(36)
Total cash dividends paid------
Issuance (retirement) of stock, net(223)98135
Issuance (retirement) of debt, net(31)(582)3,871
Total cash from financing(305)(529)3,971
NET CHANGE IN CASH
Foreign exchange effects1.14(6.22)(3.21)
Net change in cash625290(466)
Net cash-begin balance/reserved for future use8815911,058
Net cash-end balance/reserved for future use1,506881591
SUPPLEMENTAL INCOME
Depreciation, supplemental303027
Cash interest paid, supplemental333271138
Cash taxes paid, supplemental17895271
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.